CD206 TARGETED PEPTIDE CONJUGATES AND METHODS OF USING THE SAME

Title:

CD206 TARGETED PEPTIDE CONJUGATES AND METHODS OF USING THE SAME

Document Type and Number:

WIPO Patent Application WO/2023/154564

Kind Code:

A3

Abstract:

CD206 targeted peptide conjugates are provided. Aspects of the conjugates include a CD206 binding peptide conjugated to a label or therapeutic agent. Also provided are methods of using the conjugates, e.g., in diagnostic or therapeutic applications.

More Like This:

WO/2023/025193	RECOMBINANT PROTEIN OF NERVE GROWTH FACTOR MUTANT AND USE THEREOF
JP7041187	Cell-permeable peptides, conjugates containing them, and compositions containing them.
JP6491371	Paliperidone hapten

Inventors:

JAYNES JESSE M (US)
YATES CLAYTON (US)
LOPEZ HENRY W (US)
PARKER CANDACE C (US)
LAPI SUZANNE E (US)

Application Number:

PCT/US2023/013028

Publication Date:

April 25, 2024

Filing Date:

February 14, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

RIPTIDE BIOSCIENCE INC (US)
UAB RES FOUND (US)

International Classes:

A61K47/64; A61K51/08; A61P37/00; G01N33/52; G06T7/00; C07K16/28

Attorney, Agent or Firm:

FIELD, Bret E. (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: SEALING DEVICE FOR CLOSING A LARGE BORE ACCESS OPENING

Next Patent: TISSUE SAMPLE DEVICE AND METHODS